HYDERABAD, India, July 11, 2012 /PRNewswire/ --
While the Indian pharmaceutical industry is expecting only a single digit growth rate in the near future, and is predicted to reach US$975 billion by 2013, the outlook of the vaccine industry is one of continued growth. Between 2009 and 2010, the global vaccine market grew almost 15% to US$25.3 billion, and is predicted to reach US$56.7 billion by 2017.
In this regard, CPhI Conferences announces its inaugural two-day strategic Vaccines Summit 2012, taking place from August 30-31 in Hyderabad, India. This conference focuses on the latest R&D advancements in vaccines for tuberculosis, pneumococcal conjugate, HPV, dengue, AIDS, malaria, combination and thermostable vaccines, and novel adjuvants. It also focuses on the vital concerns around vaccine manufacturing, scale up, QbD, cold chain management and technology transfer.
The event includes an exclusive seminar covering global regulations for vaccines, taking place on 29 August 2012, which features the recent government initiatives, WHO pre-qualification for vaccines, regulatory framework for India and best ways of overcoming regulatory complexities in the Emerging Markets (EMs) and Rest of the World (RoW) countries. This regulatory focused day is led by experts including Nirmal Kumar Ganguly, Distinguished Biotechnology Research Professor, Department of Biotechnology (Former Director General, Indian Council of Medical Research); Shreemanta K Parida, CEO, Vaccine Grand Challenge Program, Department of Biotechnology, Ministry of Science and Technology; Ajay Khera, Public Health Consultant and Deputy Commissioner, Child Health and Immunisation, Ministry of Health and Family Welfare; and Madhur Gupta, Technical Officer (Pharmaceuticals), WHO India.
Visit www.vaccines-summit.com/pr to view the complete programme.
About CPhI Conferences:
CPhI Conferences is a UBM brand. UBM (LSE: UBM) organises more than 300 events in 21 countries across industry sectors including food, pharma, energy, property, aviation, telecom and more. Our expertise is a proven guarantee of the quality of our events.
About UBM India:
UBM India is a subsidiary of UBM plc, which is the second largest independent exhibition organiser in the world. It is the largest trade exhibition organiser in India, responsible for 26 exhibitions in different locations across the country. The company is also involved in the organisation of conference programmes throughout India and in the publications of trade journals and magazines. For further details please visit the UBM India website, http://www.ubmindia.in.
SOURCE UBM India Pvt. Ltd.